Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Clements

Showing results (161-170 of 320) with videos related to

Pageof 32
Sort By:
The Pediatric Infectious Disease Journal|August 1, 1996
Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsR A Karron, M Makhene, K Gay, et al.
The Journal of Infectious Diseases|October 1, 1983
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials NetworkM C Keefer, R Belshe, B Graham, et al.
Recombinant DNA Technical Bulletin|September 1, 1983
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccinesT A Brown, M L Clements, B R Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activationJ L Clements, S E Ross-Barta, L T Tygrett, et al.
JAMA|August 11, 1989
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineP G Miotti, K E Nelson, G A Dallabetta, et al.
International Immunology|November 1, 1993
Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytesJ L Clements, G Winslow, C Donahue, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials NetworkR Viscidi, E Ellerbeck, L Garrison, et al.
The Journal of Infectious Diseases|October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccinesS Zolla-Pazner, S Xu, S Burda, et al.
Pageof 32

Showing results (161-170 of 320) with videos related to

Sort By:
Pageof 32
The Pediatric Infectious Disease Journal|August 1, 1996
Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infantsR A Karron, M Makhene, K Gay, et al.
The Journal of Infectious Diseases|October 1, 1983
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials NetworkM C Keefer, R Belshe, B Graham, et al.
Recombinant DNA Technical Bulletin|September 1, 1983
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccinesT A Brown, M L Clements, B R Murphy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activationJ L Clements, S E Ross-Barta, L T Tygrett, et al.
JAMA|August 11, 1989
The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineP G Miotti, K E Nelson, G A Dallabetta, et al.
International Immunology|November 1, 1993
Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytesJ L Clements, G Winslow, C Donahue, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials NetworkR Viscidi, E Ellerbeck, L Garrison, et al.
The Journal of Infectious Diseases|October 21, 1998
Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccinesS Zolla-Pazner, S Xu, S Burda, et al.
Pageof 32